KIMS IPO - ICICI Direct's Investment Rationale

College building of Krishna Institute of Medical Sciences. (Source: Company website)

KIMS IPO - ICICI Direct's Investment Rationale


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Started by renowned cardiothoracic surgeon Dr. Bhaskara Rao Bollineni in 2000, Krishna Institute of Medical Sciences is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana.

As of FY21, the company operates nine multi-specialty hospitals with a bed capacity of 3,064, including over 2,500 operational beds.

It offers a comprehensive range of healthcare services across 25 specialties and super specialties.

The company has a strategic focus on the southern India healthcare market where it has a strong understanding of regional nuances, customer culture and the mindset of medical professionals and where there is significant and growing need for quality and affordable healthcare services.

Click on the attachment to read the full report:

ICICI Direct Krishna Institute of Medical Sciences Hospitals IPO Review.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.